Incidence of Ischaemic Heart Disease in Men and Women With End-Stage Kidney Disease: A Cohort Study

被引:5
|
作者
O'Lone, Emma [1 ,2 ]
Kelly, Patrick J. [1 ]
Masson, Philip [1 ,2 ]
Kotwal, Sradha [3 ,4 ]
Gallagher, Martin [5 ,6 ]
Cass, Alan [7 ]
Craig, Jonathan C. [8 ]
Webster, Angela C. [1 ,9 ]
机构
[1] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia
[2] Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia
[3] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia
[4] Prince Wales Hosp, Sydney, NSW, Australia
[5] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[6] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia
[7] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia
[8] Hinders Univ, Coll Med & Publ Hlth, Adelaide, SA, Australia
[9] Westmead Hosp, Ctr Renal & Transplant Res, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
Cardiac disease; Epidemiology; End-stage kidney disease; ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; CORONARY-HEART; RENAL-DISEASE; PRIMARY-PREVENTION; RANDOMIZED-TRIALS; SEX-DIFFERENCES; EVENT RATES; TRENDS; RISK;
D O I
10.1016/j.hlc.2020.03.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The incidence of ischaemic heart disease (IHD) has fallen consistently in the general population; attributed to effective primary prevention strategies. Differences in incidence have been demonstrated by sex. Whether this fall in incidence and sex differences is mirrored in people with end-stage kidney disease (ESKD) is unclear. We aimed to establish the relative risk of H-ID events in the ESKD population. Methods We performed a retrospective cohort study from 2000 to 2010 in people with ESKD in New South Wales. We performed data linkage of the Australia and New Zealand Dialysis and Transplant Registry and state wide hospital admission and death registry data and compared this to general population data. The primary outcome was the incidence rate, incidence rate ratio (IRR), and time-trend for any IHD event. We calculated these using indirect standardisation by IHD event. Results 10,766 participants, contributed 44,149 years of observation time. Incidence rates were substantially higher than the general population for all IHD events (any IHD event: IRR 1.8, 95% confidence interval [CI] 1.7-1.9 for men, IRR 3.4, 95% CI 3.1-3.6 for women). Excess risk was higher in younger people (age 30-49 IRR 4.8, 95% CI 4.2-5.4), and in women with a three-fold increase risk overall and nearly a 10-fold increase in risk in young women (female age 30-49 years: IRR 9.8 95% CI 7.7-12.3), results were similar for angina and acute myocardial infarction. Ischaemic heart disease rates showed some decline for men over time, (ratio of IRR 0.93, 95% CI 0.90-0.95) but were stable for women (ratio of IRR 0.97, 95% CI 0.94-1.01). Conclusions People with ESKD have substantially higher rates of IHD than the general population, especially women, in whom no improvement appears evident over the past 10 years.
引用
收藏
页码:1517 / 1526
页数:10
相关论文
共 50 条
  • [21] Heart Failure in End-Stage Kidney Disease: Pathophysiology, Diagnosis, and Therapeutic Strategies
    Rangaswami, Janani
    McCullough, Peter A.
    SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 600 - 617
  • [22] Endotoxemia in End-Stage Kidney Disease
    Wong, Jonathan
    Vilar, Enric
    Farrington, Ken
    SEMINARS IN DIALYSIS, 2015, 28 (01) : 59 - 67
  • [23] Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry
    Abd ElHafeez, Samar
    Kramer, Anneke
    Arici, Mustafa
    Arnol, Miha
    Asberg, Anders
    Bell, Samira
    Belliere, Julie
    Diaz Corte, Carmen
    Fernandez Fresnedo, Gema
    Hemmelder, Marc
    Heylen, Line
    Hommel, Kristine
    Kerschbaum, Julia
    Naumovic, Radomir
    Nitsch, Dorothea
    Santamaria, Rafael
    Finne, Patrik
    Palsson, Runolfur
    Pippias, Maria
    Resic, Halima
    Rosenberg, Mai
    Santiuste de Pablos, Carmen
    Segelmark, Marten
    Schwartz Sorensen, Soren
    Jose Soler, Maria
    Vidal, Enrico
    Jager, Kitty J.
    Ortiz, Alberto
    Stel, Vianda S.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (09) : 1449 - 1460
  • [24] A cohort study found a high risk of end-stage kidney disease associated with acromegaly
    Hong, Sangmo
    Kim, Kyung-Soo
    Han, Kyungdo
    Park, Cheol-Young
    KIDNEY INTERNATIONAL, 2023, 104 (04) : 820 - 827
  • [25] Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study
    Palmer, Suetonia C.
    Ruospo, Marinella
    Wong, Germaine
    Craig, Jonathan C.
    Petruzzi, Massimo
    De Benedittis, Michele
    Ford, Pauline
    Johnson, David W.
    Tonelli, Marcello
    Natale, Patrizia
    Saglimbene, Valeria
    Pellegrini, Fabio
    Celia, Eduardo
    Gelfman, Ruben
    Leal, Miguel R.
    Torok, Marietta
    Stroumza, Paul
    Bednarek-Skublewska, Anna
    Dulawa, Jan
    Frantzen, Luc
    Ferrari, Juan Nin
    del Castillo, Domingo
    Bernat, Amparo G.
    Hegbrant, Jorgen
    Wollheim, Charlotta
    Gargano, Letizia
    Bots, Casper P.
    Strippoli, Giovanni F. M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (04) : 666 - 676
  • [26] Longitudinal Blood Pressure in Late-Stage Chronic Kidney Disease and the Risk of End-Stage Kidney Disease or Mortality (Best Blood Pressure in Chronic Kidney Disease Study)
    Sood, Manish M.
    Akbari, Ayub
    Manuel, Douglas G.
    Ruzicka, Marcel
    Hiremath, Swapnil
    Zimmerman, Deborah
    McCormick, Brendan
    Taljaard, Monica
    HYPERTENSION, 2017, 70 (06) : 1210 - 1218
  • [27] Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease
    Clemmer, John S.
    Shafi, Tariq
    Obi, Yoshitsugu
    CURRENT HYPERTENSION REPORTS, 2022, 24 (10) : 413 - 424
  • [28] Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease
    Omran, Jad
    Al-Dadah, Ashraf
    Dellsperger, Kevin C.
    CARDIORENAL MEDICINE, 2013, 3 (03) : 165 - 177
  • [29] Familial aggregation of end-stage kidney disease in Brazil
    Madeira, EPQ
    Santos, OD
    Santos, SFF
    da Silva, LA
    Innocenzi, AM
    Santoro-Lopes, G
    NEPHRON, 2002, 91 (04): : 666 - 670
  • [30] End-Stage Kidney Disease and Kidney Transplantation in HIV-Positive Patients: An Observational Cohort Study
    Gathogo, Esther
    Jose, Sophie
    Jones, Rachael
    Levy, Jeremy B.
    Mackie, Nicola E.
    Booth, John
    Connolly, John
    Johnson, Margaret
    Leen, Clifford
    Williams, Debbie
    Sabin, Caroline A.
    Post, Frank A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : 177 - 180